Accuracy of the S100β protein as a marker of brain damage in traumatic brain injury

References

• Gabbita SP, Scheff SW, Menard RM, Roberts K, Fugaccia I, Zemlan FP. Cleaved-tau: A biomarker of neuronal damage after traumatic brain injury. Journal of Neurotrauma 2005; 22: 83–94
   PubMed Web of Science ®Google Scholar
• Honda M, Tsuruta R, Kaneko T, Kasaoka S, Yagi T, Todani M, Fujita M, Izumi T, Maekawa T. Serum glial fibrillary acidic protein is a highly specific biomarker for traumatic brain injury in humans compared with S-100β and neuron- specific-enolase. Journal of Trauma 2010; 69: 104–109
   PubMed Web of Science ®Google Scholar
• De Kruijk JR, Leffers P, Menheere PP, Meerhoff S, Twijnstra A. S-100B and neuron-specific enolase in serum of mild traumatic brain injury patients. A comparison with health controls. Acta Neurologica Scandinavica 2001; 103: 175–179
   PubMed Web of Science ®Google Scholar
• Biberthaler P, Mussack T, Kanz KG, Linsemaier U, Pfeifer KJ, Mutschler W, Jochum M. Identification of high-risk patientsafter minor craniocerebral trauma. Measurement of nerve tissue protein S 100. Unfallchirurgie 2004; 107: 197–202
   Google Scholar
• Zemlan FP, Jauch EC, Mulchahey JJ, Gabbita SP, Rosenberg WS, Speciale SG, Zuccarello M. C-tau biomarker of neuronal damage in severe brain injured patients: Association with elevated intracranial lesion pressure and clinical outcome. Brain Research 2002; 947: 131–139
   PubMed Web of Science ®Google Scholar
• Beaudeux J, Dequen L, Foglietti M. Pathopysiologic aspects of S-100beta protein: A new biological marker of brain pathology. Annales de Biologie Clinique (Paris) 1999; 57: 261–272
   PubMedGoogle Scholar
• Murillo-Cabezas F, Muñoz-Sáchez MA, Rincón-Ferrari MD, Martín-Rodríguez JF, Amaya-Villar R, García-González S, León-Carrión J. The prognostic value of the temporal course of S100β eta protein in post-acute severe brain injury: A prospective and observational study. Brain Injury 2010; 24: 609–619
   PubMed Web of Science ®Google Scholar
• Marchi N, Cavaglia M, Fazio V, Bhudia S, Hallene K, Janigro D. Peripheral markers of blood-brain barrier damage. Clinica Chimica Acta 2004; 342: 1–12
   PubMed Web of Science ®Google Scholar
• Servadei F, Teasdale G, Merry G. Defining acute mild head injury in adults: A proposal based on prognostic factors, diagnosis, and management. Journal of Neurotrauma 2001; 18: 657–664
   PubMed Web of Science ®Google Scholar
• Biberthaler P, Linsenmeier U, Pfeifer KJ, Kroetz M, Mussack T, Kanz KG, Hoecherl EF, Jonas F, Marzi I, Leucht P, Jochum M, Mutschler W. Serum S-100B concentration provides additional information for the indication of Computed tomography in patients after minor head injury: A prospective multicenter study. Shock 2006; 25: 446–453
   PubMed Web of Science ®Google Scholar
• Müller K, Townend W, Biasca N, Undén J, Waterloo K, Romner B, Ingebrigtsen T. S100Β serum level predicts computed tomography findings after minor head injury. Journal of Trauma 2007; 62: 1452–1456
   PubMed Web of Science ®Google Scholar
• Shackford SR, Wald SL, Ross S. The clinical utility of CT scanning and neurological examination in the management of patients with minor head injuries. Journal of Trauma 1992; 33: 385–394
   PubMed Web of Science ®Google Scholar
• Raabe A, Grolms C, Sorge O, et al. Serum S-100B protein in severe head injury. Neurosurgery 1999; 45: 477–483
   PubMed Web of Science ®Google Scholar
• Townend W, Dibble C, Abid K, Vail A, Sherwood R, Lecky F. Rapid elimination of protein S-100B from serum after minor head trauma. Journal of Neurotrauma 2006; 23: 149–155
   PubMed Web of Science ®Google Scholar
• Jönsson H, Johnsson P, Höglund P, Alling C, Blomquist S. Elimination of S100Β and renal function after cardiac surgery. Journal of Cardiothoracic and Vascular Anesthia 2000; 14: 698–701
   PubMed Web of Science ®Google Scholar
• Dimopoulou I, Korfias S, Dafni U, Anthi A, Psachoulia C, Jullien G, Sakas DE, Roussos C. Protein S-100b serum levels in trauma induced brain death. Neurology 2003; 60: 947–951
   PubMed Web of Science ®Google Scholar
• Raabe A, Seifert V. Protein S-100B as a serum marker of brain damage in severe head injury: Preliminary results. Neurosurgery Review 2000; 23: 136–138
   PubMed Web of Science ®Google Scholar
• Topal NB, Hakyemez B, Erdogan C, Bulut M, Koksal O, Akkose S, Dogan S, Parlak M, Ozguc H, Korfali E. MR imaging in the detection of diffuse axonal injury with mild traumatic brain injury. Neurological Research 2008; 30: 974–978
   PubMed Web of Science ®Google Scholar
• Stiell IG, Clement CM, Rowe BH, Schull MJ, Brison R, Cass D, Eisenhauer MA, McKnight RD, Bandiera G, Holroyd B, Lee JS, Dreyer J, Worthington JR, Reardon M, Greenberg G, Lesiuk H, MacPhail I, Wells GA. Comparison of the Canadian CT head rule and the New Orleans criteria in patients with minor head injury. Journal of the American Medical Association 2005; 294: 1511–1518
   PubMed Web of Science ®Google Scholar
• Setnik L, Bazarian JJ. The characteristics of patients who do not seek medical treatment for traumatic brain injury. Brain Injury 2007; 21: 1–9
   PubMed Web of Science ®Google Scholar
• Pelinka LE, Toegel E, Mauritz W, Redl H. Serum S 100 B: A marker of brain damage in traumatic brain injury with and without multiple trauma. Shock 2003; 19: 195–200
   PubMed Web of Science ®Google Scholar
• Anderson RE, Hansson LO, Nilsson O, Dijlai-Merzoug R, Settergren G. High serum S100Β levels for trauma patients without head injuries. Neurosurgery 2001; 48: 1255–1258
   PubMed Web of Science ®Google Scholar
• Savola O, Pyhtinen J, Leino TK, Siitonen S, Niemela O, Hillbom M. Effets of head and extracranial injuries on serum protein S100B levels in trauma patients. Journal of Trauma 2004; 56: 1229–1234
   PubMed Web of Science ®Google Scholar